Myelodysplastic syndrome.
Mufti G, List AF, Gore SD, Ho AY.
Mufti G, et al.
Hematology Am Soc Hematol Educ Program. 2003:176-99. doi: 10.1182/asheducation-2003.1.176.
Hematology Am Soc Hematol Educ Program. 2003.
PMID: 14633782
Review.
The review provides an update of the role of small molecule inhibitors of VEGF receptor tyrosine kinase, arsenic trioxide, oral matrix metalloprotease inhibitors, farnesyl transferase inhibitors, and imatinib mesylate in the treatment of MDS subgroups. In Section II, Dr. Steven …
The review provides an update of the role of small molecule inhibitors of VEGF receptor tyrosine kinase, arsenic trioxide, oral matrix metal …